Table of Contents What Cagrilintide and Retatrutide Are and How They Work Approved Uses and Current Clinical Evidence in the UK How These Medicines May Affect Men Specifically Dosage, Administration, and What to Expect Side Effects, Risks, and Safety Considerations Availability on the NHS and Next Steps for Treatment Scientific References Frequently Asked Questions What Cagrilintide and Retatrutide Are and How They Work Cagrilintide is a long-acting amylin analogue that promotes satiety and slows gastric emptying, while retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors to reduce appetite, enhance insulin secretion, and increase energy expenditure
Support for gut lining health, which can improve absorption of dietary protein on aggressive nutrition plans
Partnered with FDA Regulated 503b Pharmacies and State Inspected 503a Pharmacies in the USA
Two popular regenerative approaches
Emerging preclinical and early clinical studies in humans highlight the potential of BPC-157 and TB-500
That equals eight 5 mg vials after rounding up